Acceptability and feasibility of patient-reported outcome measures for atopic eczema: an evaluation of PROMs from the HOME core outcome set
Jitske Dijkstra(Amsterdam UMC Location University of Amsterdam), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Phyllis I. Spuls, Jolanda Maaskant(Emma Kinderziekenhuis), Eva Knöps(Amsterdam UMC Location University of Amsterdam)
Cited by 0
Related Papers
Definition of treatment goals for moderate to severe psoriasis: a European consensus
|Archives of Dermatological Research|2010|892
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
|Journal of Clinical Oncology|2015|619
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
|Journal of the European Academy of Dermatology and Venereology|2022|419
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
|Journal of Investigative Dermatology|2016|377
European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations
|Journal of the European Academy of Dermatology and Venereology|2022|271